APA-Zitierstil (7. Ausg.)

Trautmann, M., & Fröhling, S. (2017). FUS-DDIT3 fusion protein-driven IGF-IR signaling is a therapeutic target in myxoid liposarcoma. Clinical cancer research, 23(20), . https://doi.org/10.1158/1078-0432.CCR-17-0130

Chicago-Zitierstil (17. Ausg.)

Trautmann, Marcel, und Stefan Fröhling. "FUS-DDIT3 Fusion Protein-driven IGF-IR Signaling Is a Therapeutic Target in Myxoid Liposarcoma." Clinical Cancer Research 23, no. 20 (2017). https://doi.org/10.1158/1078-0432.CCR-17-0130.

MLA-Zitierstil (9. Ausg.)

Trautmann, Marcel, und Stefan Fröhling. "FUS-DDIT3 Fusion Protein-driven IGF-IR Signaling Is a Therapeutic Target in Myxoid Liposarcoma." Clinical Cancer Research, vol. 23, no. 20, 2017, https://doi.org/10.1158/1078-0432.CCR-17-0130.